NL-OMON27965招募中不适用
Anticoagulants for living fetuses for women with recurrent miscarriage and inherited thrombophilia.
Academic Medical Center Amsterdam0 个研究点目标入组 399 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 399
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Women with recurrent miscarriage (>= 2) irrespective of gestational age;
- •2. Confirmed inherited thrombophilia; factor V Leiden mutation, prothrombin gene mutation (G20210A), protein S deficiency, protein C deficiency or antithrombin deficiency or a combination hereof. Protein S, -C and antithrombin deficiencies need to be confirmed by two independent tests, performed on two separate occasions and not during pregnancy or anticoagulant therapy;
排除标准
- •1. Duration of current pregnancy >= 7 weeks;
- •2. Indication for anticoagulant treatment during pregnancy (for instance prosthetic heart valves, a history of venous thromboembolism or antiphospholipid syndrome);
研究者
相似试验
进行中（未招募）
1 期
Anticoagulants for living fetuses for women with recurrent miscarriage and inherited blood clotting disorders; ALIFE2 studyEUCTR2012-001447-43-ATAcademic Medical Center Amsterdam399
招募中
3 期
Anticoagulants for Living Fetuses in women with recurrent miscarriage and inherited thrombophilia; ALIFE2 studyhabitual abortionrecurrent miscarriage1006447710000211NL-OMON43583Academisch Medisch Centrum200
进行中（未招募）
1 期
Anticoagulants (blooding thinning medications) for pregnant women who have suffered 2 or more miscarriages and inherited thrombophilia (increased clotting tendency)Inherited thrombophilia in recurrent miscarriageEUCTR2015-002357-35-GBResearch, Development & Innovation Department, UHCW NHS Trust400
招募中
2 期
Anticoagulant threpy for patients with obstetric antiphospholipid syndrome.Antiphospholipid syndromeJPRN-jRCTs041180093Sugiura Mayumi200
撤回
不适用
Sildenafil Citrate Added to Low Molecular Weight Heparin and Low Dose Aspirin in High-risk PregnancyHigh Risk PregnancyNCT04110444Fayoum University Hospital